Suvretta Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-99,999
| Closed | -$990K | – | 95 |
|
|
2022
Q2 | $990K | Hold |
99,999
| – | – | 0.04% | 84 |
|
|
2022
Q1 | $984K | Hold |
99,999
| – | – | 0.03% | 80 |
|
|
2021
Q4 | $976K | Hold |
99,999
| – | – | 0.02% | 86 |
|
|
2021
Q3 | $978K | Hold |
99,999
| – | – | 0.02% | 97 |
|
|
2021
Q2 | $984K | Hold |
99,999
| – | – | 0.01% | 114 |
|
|
2021
Q1 | $998K | Hold |
99,999
| – | – | 0.01% | 98 |
|
|
2020
Q4 | $1.01M | Buy |
+99,999
| New | +$1.01M | 0.01% | 97 |
|